Aldeyra Therapeutics (NASDAQ: ALDX)
Aldeyra Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Aldeyra Therapeutics Company Info
Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.
News & Analysis
Why Aldeyra Therapeutics Stock Is Sinking Today
The company plans to conduct a public stock offering.
Why Aldeyra Therapeutics Stock Is Soaring Today
The company reported great clinical results for its lead pipeline candidate.
Why Aldeyra Therapeutics Stock Is Jumping Today
The company announced the pricing of a public stock offering.
Why Aldeyra Therapeutics Stock Soared Today
An analyst is very bullish about the biotech stock.
Here's Why Aldeyra Therapeutics Stock Soared as Much as 79.1% Today
The small-cap pharma announced positive results from a phase 3 trial.
Valuation
Earnings Transcripts
Aldeyra Therapeutics (ALDX) Q2 2022 Earnings Call Transcript
ALDX earnings call for the period ending June 30, 2022.
Aldeyra Therapeutics (ALDX) Q1 2022 Earnings Call Transcript
ALDX earnings call for the period ending March 31, 2022.
Aldeyra Therapeutics (ALDX) Q4 2021 Earnings Call Transcript
ALDX earnings call for the period ending December 31, 2021.
Aldeyra Therapeutics (ALDX) Q3 2021 Earnings Call Transcript
ALDX earnings call for the period ending September 30, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.